Member States shall take all appropriate measures to ensure that the holder of the marketing authorization for a medicinal product and, where appropriate, the holder of the manufacturing authorization, furnish proof of the controls carried out on the medicinal product and/or the ingredients and of the controls carried out at an intermediate stage of the manufacturing process, in accordance with the methods laid down in Article 8(3)(h).
Art. 112 Directive (EU) 2001/83
Opinion of Advocate General Bobek delivered on 7 December 2017. Proceedings brought by Astellas Pharma GmbH.Decision
… mają obowiązek wzajemnego przekazywania sobie informacji na podstawie przepisów dyrektywy 2001/83 [Zobacz art. 112 dyrektywy 2001/83.], a także w ramach ogólnego obowiązku lojalnej współpracy przewidzianego w art. 4 ust. 3 TUE. …
7 Dec 2017 · 62016CC0557
Raad van State, 29-08-2012, 201009468/1/A3Decision
… gegevens onjuist zijn, of niet gewijzigd in overeenstemming met artikel 23 van Richtlijn 2001/83 of wanneer de in artikel 112 van Richtlijn 2001/83 bedoelde controles niet hebben plaatsgevonden. Ingevolge artikel 1, aanhef en onder p en q, …
29 Aug 2012 · ECLI:NL:RVS:2012:BX5965
Changed on 26 Jan 2007
Member States shall take all appropriate measures to ensure that the holder of the marketing authorization for a medicinal product and, where appropriate, the holder of the manufacturing authorization, furnish proof of the controls carried out on the medicinal product and/ or the ingredients and of the controls carried out at an intermediate stage of the manufacturing process, in accordance with the methods laid down in Article 8(3)(h).
- 26 Jan 2007 – todayin force
- 8 Feb 2003 – 26 Jan 2007earlier wording
- 6 Nov 2001 – 8 Feb 2003earlier wording
Versions are held from 6 Nov 2001; the article may be older.